Hundreds of students explore healthcare careers at travelling roadshow
Grade 10 and 11 students from North Peace Secondary School (NPSS) took part in the Healthcare Travelling Roadshow on May 26th and 27th.
Introduced in 2010 by Dr. Sean Maurice of the medical program at Prince George's University of Northern British Columbia (UNBC), the event had a dual purpose for both the college and high school students involved.
The high school students got to see potential opportunities, while the college-aged undergraduates got a glimpse of the rural community they could be serving when they enter the workforce.
Maurice says the event focuses on kids from rural communities who face 'more barriers' in their post-secondary lives.
'In a lot of [rural] places where there are a lot of blue-collar jobs,' says Maurice, '[where] you don't necessarily need to have post-secondary education.
'[Then there's] a lot of kids who have parents who aren't familiar with post-secondary.
'If you feel you need to go to Vancouver for university, it's just far away. It feels very different. So we're just trying to help get them over that barrier.'
Brian Campbell of School District 60 told
Energeticcity.ca
approximately 200 students from NPSS took part to see 'what potential careers' they could consider after graduation.
Campbell is the district principal of careers and international education.
'The more that we can expose students to potential careers, the better they're going to be able to make informed choices of what they want to do,' said Campbell.
'The healthcare field is so wide, [NPSS students] could talk to students who are studying in [that] field and get to try some things hands on.'
Students from UNBC demonstrated the opportunities available in careers such as medicine, nursing, psychiatric nursing, dental hygiene, laboratory technology, midwifery, kinesiology, biomedical engineering and respiratory therapy.
'I think it's really important for students to realize that they can have the opportunity to train in the north and stay in the north,' said Campbell. 'That really helps build strong northern communities.'
The roadshow has made regular trips to Fort St. John since its beginnings in 2010. It will also make trips to both Dawson Creek and Tumbler Ridge during the last week of May, according to a news release.
The Healthcare Travelling Roadshow was also funded in part by partnership with the Northern Medical Programs Trust, Rural Education Action Plan, Interior Health, UNBC, and University of British Columbia Faculty of Medicine.
It has exposed more than 16,500 students to the wonders of the healthcare field, according to the release.
More details about the Healthcare Travelling Roadshow can be found on its
website
.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Los Angeles Times
2 days ago
- Los Angeles Times
‘A continual assault.' How UCLA's research faculty is grappling with Trump funding freeze
Their medical research focuses on potentially lifesaving breakthroughs in cancer treatment, and developing tools to more easily diagnose debilitating diseases. Their studies in mathematics could make online systems more robust and secure. But as the academic year opens, the work of UCLA's professors in these and many other fields has been imperiled by the Trump administration's suspension of $584 million in grant funding, which University of California President James B. Milliken called a 'death knell' to its transformative research. The freeze came after a July 29 U.S. Department of Justice finding that the university had violated the civil rights of Jewish and Israeli students by providing an inadequate response to alleged antisemitism they faced after the Oct. 7, 2023, Hamas attack. The fight over the funding stoppage intensified Friday after the Trump administration demanded that UCLA pay a $1-billion fine, among other concessions, to resolve the accusations — and California Gov. Gavin Newsom said the state will sue, calling the proposal 'extortion.' Amid heightened tensions in Westwood, thousands of university academics are in limbo. In total, at least 800 grants, mostly from the National Science Foundation and the National Institutes of Health, have been frozen. UCLA scholars described days of confusion as they struggle to understand how the loss of grants would affect their work and scramble to uncover new funding sources — or roles that would ensure their continued pay, or that of their colleagues. While professors still have jobs and paychecks to draw on, many others, including graduate students, rely on grant funding for their salaries, tuition and healthcare. At least for the moment, though, several academics told The Times that their work had not yet be interrupted. So far, no layoffs have been announced. Sydney Campbell, a pancreatic cancer researcher and postdoctoral scholar at UCLA's David Geffen School of Medicine, said her work — which aims to understand how diet affects the disease — is continuing for now. She has an independent fellowship that 'hopefully will protect the majority of my salary.' But others, she said, don't have that luxury. 'It is absolutely going to affect people's livelihoods. I already know of people ... with families who are having to take pay cuts almost immediately,' said Campbell, who works for a lab that has lost two National Institutes of Health grants, including one that funds her research. Pancreatic cancer is among the most deadly of cancers, but Campbell's work could lead to a better understanding of it, paving the way for more robust prophylactic programs — and treatment plans — that may ultimately help tame the scourge. 'Understanding how diet can impact cancer development could lead to preventive strategies that we can recommend to patients in the future,' she said. 'Right now we can't effectively do that because we don't have the information about the underlying biology. Our studies will help us actually be able to make recommendations based on science.' Campbell's work — and that of many others at UCLA — is potentially groundbreaking. But it could soon be put on hold. 'We have people who don't know if they're going to be able to purchase experimental materials for the rest of the month,' she said. For some, the cuts have triggered something close to an existential crisis. After professor Dino Di Carlo, chair of the UCLA Samueli Bioengineering Department, learned about 20 grants were suspended there — including four in his lab worth about $1 million — he felt a profound sadness. He said he doesn't know why his grants were frozen, and there may not be money to pay his six researchers. So Di Carlo, who is researching diagnostics for Lyme and other tick-borne diseases, took to LinkedIn, where he penned a post invoking the Franz Kafka novel 'The Trial.' The unsettling tale is about a man named Josef K. who wakes up and finds himself under arrest and then on trial — with no understanding of the situation. 'Like Josef K., the people actually affected — the public, young scientists, patients waiting for better treatments and diagnostic tools — are left asking: What crime did we commit?' wrote Di Carlo. 'They are being judged by a system that no longer explains itself.' The LinkedIn post quickly attracted dozens of comments and more than 1,000 other responses. Di Carlo, who has been working to find jobs for researchers who depend on paychecks that come from now-suspended grants, said he appreciated the support. But, goodwill has its limits. 'It doesn't pay the rent for a student this month,' he said. Di Carlo's research is partly focused on developing an at-home test that would detect Lyme and other tick-borne diseases, which are on the rise. Because no such product is currently approved by the U.S. Food and Drug Administration, he said, people who've experienced a tick bite have to wait for lab results to confirm their infection. 'This delay in diagnosis prevents timely treatment, allowing the disease to progress and potentially lead to long-term health issues,' he said. 'A rapid, point-of-care test would allow individuals to receive immediate results, enabling early treatment with antibiotics when the disease is most easily addressed, significantly reducing the risk of chronic symptoms and improving health outcomes.' Di Carlo lamented what he called 'a continual assault on the scientific community' by the Trump administration, which has canceled billions of dollars in National Institutes of Health funding for universities across the country. It 'just ... hasn't let up,' Di Carlo said. Some professors who've lost grants have spent long hours scrambling to secure new sources of funding. Di Carlo said he was in meetings all week to identity which researchers are affected by the cuts, and to try to figure out, 'Can we support those students?' He has also sought to determine whether some could be moved to other projects that still have funding, or be given teaching assistant positions, among other options. He's not alone in those efforts. Mathematics professor Terence Tao also has lost a grant worth about $750,000. But Tao said that he was more distressed by the freezing of a $25-million grant for UCLA's Institute for Pure and Applied Mathematics. The funding loss for the institute, where Tao is director of special projects, is 'actually quite existential,' he said, because the grant is 'needed to fund operations' there. Tao, who is the James and Carol Collins chair in the College of Letters and Sciences, said the pain goes beyond the loss of funds. 'The abruptness — and basically the lack of due process in general — just compounds the damage,' said Tao. 'We got no notice.' A luminary in his field, Tao conducts research that examines, in part, whether a group of numbers are random or structured. His work could lead to advances in cryptography that may eventually make online systems — such as those used for financial transactions — more secure. 'It is important to do this kind of research — if we don't, it's possible that an adversary, for example, could actually discover these weaknesses that we are not looking for at all,' Tao said. 'So you do need this extra theoretical confirmation that things that you think are working actually do work as intended, [and you need to] also explore the negative space of what doesn't work.' Tao said he's been heartened by donations that the mathematics institute has received from private donors in recent days — about $100,000 so far. 'We are scrambling for short-term funding because we need to just keep the lights on for the next few months,' said Tao. Rafael Jaime, president of United Auto Workers Local 4811, which represents 48,000 academic workers within the University of California — including about 8,000 at UCLA — said he was not aware of any workers who haven't been paid so far, but that the issue could come to a head at the end of August. He said that the UC system 'should do everything that it can to ensure that workers aren't left without pay.' A major stressor for academics: the uncertainty. Some researchers whose grants were suspended said they have not received much guidance from UCLA on a path forward. Some of that anxiety was vented on Zoom calls last week, including a UCLA-wide call attended by about 3,000 faculty members. UCLA administrators said they are exploring stopgap options, including potential emergency 'bridge' funding to grantees to pay researchers or keep up labs such as those that use rodents as subjects. Some UCLA academics worried about a brain drain. Di Carlo said that undergraduate students he advises have begun asking for his advice on relocating to universities abroad for graduate school. 'This has been the first time that I've seen undergraduate students that have asked about foreign universities for their graduate studies,' he said. 'I hear, 'What about Switzerland? ... What about University of Tokyo?' This assault on science is making the students think that this is not the place for them.' But arguably researchers' most pressing concern is continuing their work. Campbell explained that she has personally been affected by pancreatic cancer — she lost someone close to her to it. She and her peers do the research 'for the families' who've also been touched by the disease. 'That the work that's already in progress has the chance of being stopped in some way is really disappointing,' she said. 'Not just for me, but for all those patients I could potentially help.'
Yahoo
09-07-2025
- Yahoo
2 Ultra-High-Yield Dividend Stocks at 10-Year Lows to Buy in July
The packaged food industry is facing its largest downturn in over a decade. Consumers are seeking alternatives amid growing health concerns and lifestyle changes. Conagra Brands and Campbell's have become too cheap to ignore. 10 stocks we like better than Conagra Brands › Packaged food giants Conagra Brands (NYSE: CAG) and The Campbell's Company (NASDAQ: CPB) are both down more than 25% year to date and are hovering around their lowest levels in over a decade. Both companies are industry giants. Conagra owns brands like Orville Redenbacher's, Slim Jim, Boom Chicka Pop, Hunt's, Reddi-Wip, Marie Callender's, and more. In addition to its flagship soup line, Campbell's also owns a variety of pasta sauce and dip brands, as well as snacks like Pepperidge Farm, Kettle, Cape Cod, Snyder's of Hanover, Lance, Goldfish, and more. Conagra and Campbell's stocks are so beaten down that they yield 6.8% and 5.1%, respectively. Here's why the sell-off in both high-yield dividend stocks is a buying opportunity for patient investors. The packaged food industry has faced numerous challenges in recent years. Most recently, pullbacks in consumer spending and inflation have pressured consumer goods companies -- but the downturn is particularly bad for packaged food names. Packaged food companies are facing macroeconomic headwinds and changes in consumer behavior. A shift away from processed and packaged foods toward healthier options presents a significant challenge for the industry. Especially from companies that sell frozen and processed meals rather than just snacks and beverages. The Trump administration established the Make America Healthy Again Commission to address U.S. health concerns. In April, the U.S. Department of Health and Human Services and U.S. Food and Drug Administration announced measures to phase out all petroleum-based synthetic dyes and replace them with natural ingredients. On June 25, Conagra announced that it would remove Food, Drug & Cosmetic (FD&C) colors from its U.S. frozen product portfolio by the end of 2025. The company also stated that it will not offer products with FD&C colors sold to K-12 schools beginning with the 2026 through 2027 school year and will discontinue the manufacturing of products with FD&C colors in its U.S. retail portfolio by 2027. Conagra's peers, like General Mills, Kraft Heinz, and others, made similar announcements in June. The regulatory pressure throws a wrench in an already challenging operating environment for the industry, but it could be a net positive in the long run. In addition to macro challenges and paradigm shifts in the industry, some packaged food companies have also been dealing with the aftermath of bad acquisitions. In 2018, Conagra bought Pinnacle Foods for $10.9 billion -- a disastrous move in hindsight, given the market cap of Conagra at the time of this writing is just $9.7 billion. That same year, Campbell's bought Snyder's-Lance for $6.1 billion -- making the company a major player in the snack category through chips, pretzels, popcorn, nuts, and cookies. Campbell's then bought Sovos Brands for $2.7 billion in March 2024 to diversify its product lineup through pasta sauces, dry pasta, frozen entrees, frozen pizza, yogurt, and more soup varieties. The acquisition isn't terrible, as it opens the door to more premium brands. But it did add debt to Campbell's balance sheet. Having to manage a larger interest expense makes it even harder for the company to navigate industrywide challenges. Combined, those two acquisitions cost Campbell's $8.8 billion, nearly as much as its market cap at the time of this writing of $9.2 billion. Like Conagra, Campbell's overpaid for these brands in hindsight. Conagra's and Campbell's revenues have steadily climbed over the past few years, but that's mainly due to acquisitions -- not organic growth. Meanwhile, operating margins have significantly fallen due to weakening demand. In response to the poor results, both stocks are now at their lowest levels in over a decade, which has boosted their dividend yields to their highest levels in that period. As bad as Conagra's and Campbell's results have been, both companies remain impeccable cash cows. Conagra's free cash flow (FCF) per share is $3.02 compared to its $1.40 dividend per share, while Campbell's has $2.41 in FCF per share compared to a dividend per share of $1.52. So although both companies are experiencing weakening balance sheets, at least they can still support their dividends with cash from the business. In terms of valuations, both stocks are dirt cheap -- with Campbell's sporting a 12.8 price-to-FCF and 10.5 forward price-to-earnings (P/E) ratio compared to just a 6.8 price-to-FCF ratio for Conagra and an 8.3 forward P/E. For context, Campbell's 10-year median price-to-FCF ratio is 15.8 and Conagra's is 16.3 -- illustrating just how severely discounted these stocks are compared to their historical averages. Conagra and Campbell's have been hit with a four-pronged punch of self-inflicted poor decision-making, shifts in consumer behavior, macro challenges, and regulatory changes. However, both stocks are dirt cheap and generate plenty of cash to support their high dividends. Conagra reports earnings on July 10, which will give investors a better idea of where the company is headed and the impact of changes to its food ingredients and additives. At their lowest levels in over a decade, now is a good time for income investors to scoop up shares of Conagra and Campbell's despite both stocks being heavily out of favor. Before you buy stock in Conagra Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Conagra Brands wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $695,481!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $969,935!* Now, it's worth noting Stock Advisor's total average return is 1,053% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool recommends Campbell's and Kraft Heinz. The Motley Fool has a disclosure policy. 2 Ultra-High-Yield Dividend Stocks at 10-Year Lows to Buy in July was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
03-07-2025
- Yahoo
Mass. AG Campbell sues Trump admin for sharing private health info with ICE
Massachusetts Attorney General Andrea J. Campbell has opened another front in her ongoing legal battle with the Trump administration, charging that the Republican White House exposed private health information as it prosecutes its mass deportation campaign. The lawsuit, filed by Democrat Campbell and 19 of her colleagues nationwide, in U.S. District Court in California's Northern District on Tuesday, names U.S. Health and Human Services Secretary Robert K. Kennedy Jr. and U.S. Homeland Security Secretary Kristi L. Noem as defendants. "Disclosing individuals' private health data for the purpose of immigration enforcement puts lives at risk. These actions are yet another example of the Administration creating unnecessary fear and confusion among our residents,' Campbell said in a statement. Read More: Renowned Boston restaurant considers closing after manager is detained by ICE 'Congress has made it clear that emergency Medicaid coverage extends to all individuals, regardless of immigration status. I will continue to fight against cruel and unlawful policies that harm our residents,' she said. Kennedy's advisers ordered the release of a dataset that includes the private health information of people living in California, Illinois, Washington state, and Washington, D.C., to the Department of Homeland Security, The Associated Press first reported last month. All of those states allow non-U.S. citizens to enroll in Medicaid programs that pay for their expenses using only state taxpayer dollars. Read More: Mass. AG Campbell sues Trump over obscure rule used to withhold federal funding to states The unusual data sharing of private health information, including addresses, names, social security numbers, immigration status, and claims data for enrollees in those states, was released to deportation officials as they accelerated enforcement efforts nationwide. The data could be used to help the Department of Homeland Security locate migrants in its mass deportation campaign, experts said. California Attorney General Rob Bonta, who led the legal action, said the Trump administration's data release violates federal health privacy protection laws, including the Health Insurance Portability and Accountability Act (HIPAA), the AP reported. 'This is about flouting seven decades of federal law policy and practice that have made it clear that personal healthcare data is confidential and can only be shared in certain narrow circumstances that benefit the public's health or the Medicaid program,' Bonta said during a news conference on Tuesday. The Trump administration has sought to arm deportation officials with more data on immigrants. In May, for example, a federal judge refused to block the Internal Revenue Service from sharing immigrants' tax data with Immigration and Customs Enforcement to help agents locate and detain people living without legal status in the U.S. The lawsuit filed by Campbell and her colleagues asks a federal judge to block any new transfer or use of this data for immigration enforcement purposes. It argues that the administration violated a brace of federal laws, including the Administrative Procedure Act, Social Security Act, Health Insurance Portability and Accountability Act (HIPAA), Federal Information Security Modernization Act, Privacy Act, and Spending Clause. The lawsuit also 'highlights that the Trump Administration's illegal actions are creating fear and confusion that will lead noncitizens and their family members to disenroll, or refuse to enroll, in emergency Medicaid for which they are otherwise eligible, leaving states and their safety net hospitals to foot the bill for federally mandated emergency healthcare services,' Cambell's office said in its statement. Other states joining the legal action included Arizona, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, and Washington. Trump threatens arrest of NYC mayoral candidate during visit to 'Alligator Alcatraz' Mass. has an on-time(ish) state budget: 3 big things to know about the $61B plan Here's how Rep. Marjorie Taylor Greene described support for Trump's 'big beautiful bill' Group behind MCAS ballot question broke campaign finance law, state says Wisconsin Supreme Court strikes down 1849 total abortion ban Read the original article on MassLive.
